Tech Company Financing Transactions
CoDa Therapeutics Funding Round
Domain Associates, GBS Venture Partners and private investors joined a $19.2 million Series B venture round for CoDa Therapeutics. The round was announced on 4/18/2011.
Transaction Overview
Company Name
Announced On
4/18/2011
Transaction Type
Venture Equity
Amount
$19,200,000
Round
Series B
Investors
Domain Associates (James Blair)
Proceeds Purpose
The financing will allow us to take essential steps for the development of CoDa; in particular, we will now conduct a large Phase 2 multicenter venous leg ulcer trial in the United States, New Zealand and Australia with Nexagon®, our lead product for chronic wound patients. In addition, we will continue the preclinical development of our product portfolio in our research laboratories.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12520 High Bluff Dr. 350
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
CoDa Therapeutics is a company focused on the development and commercialization of wound care therapeutics based on gap junction modulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradford Duft
Chief Financial Officer
David Pool
Chief Medical Officer
David Eisenbud
Chief Operating Officer
Tracey Sunderland
Browse more venture capital transactions:
Prev: 4/18/2011: Digby venture capital transaction
Next: 4/18/2011: Lingospot venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs